Protective efficacy of Zika vaccine in AG129 mouse model

Nature·Apr 12

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A Zika vaccine has been tested in an AG129 mouse model. The vaccine's protective efficacy in this model has been evaluated. The results of this evaluation are being reported.

Full coverage

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Frontiers·Apr 9

Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice

Nature·Nov 7

Defining Efficacy of Chikungunya Virus Candidate Vaccines: Different Endpoints Derived From the Virus—Cytokine—Ferritin (VCF) Model

Frontiers·Aug 22

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus

Nature·Dec 16

Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primates

Nature·Dec 13

Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection

Nature·Feb 26

A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice | npj Vaccines

Nature·May 7

Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine - Scientific Reports

Nature·Dec 20

View original report at Nature ↗

Fetching the latest headlines…